Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 14 of 14 entries
View as:
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
Phase: N/A
Priority: Normal
Start: 09/05/22
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 10/19/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 02/20/25
End: 12/20/25
Due: 12/20/26
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 02/04/24
Due: 02/04/25
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 02/20/25
Due: 02/20/26
Phase: N/A
Priority: Normal
Start: 07/20/24
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 06/20/22
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 05/31/21
End: 01/16/24
Due: 01/16/25
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 12/25/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 07/09/22
End: 07/09/28
Due: 07/09/29
Phase: N/A
Priority: Normal
Start: 07/06/21
End: 12/07/24
Due: 12/07/25
Phase: N/A
Priority: Normal
Start: 03/07/23
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 12/31/25
Due: 12/31/26